BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8634335)

  • 1. Transcriptional regulation of c-Fes in myeloid leukemia cells.
    He Y; Borellini F; Koch WH; Huang KX; Glazer RI
    Biochim Biophys Acta; 1996 May; 1306(2-3):179-86. PubMed ID: 8634335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
    Smithgall TE; Johnston JB; Bustin M; Glazer RI
    J Natl Cancer Inst; 1991 Jan; 83(1):42-6. PubMed ID: 1984516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor.
    Heydemann A; Juang G; Hennessy K; Parmacek MS; Simon MC
    Mol Cell Biol; 1996 Apr; 16(4):1676-86. PubMed ID: 8657143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells.
    Fang F; Ahmad S; Lei J; Klecker RW; Trepel JB; Smithgall TE; Glazer RI
    Biochemistry; 1993 Jul; 32(27):6995-7001. PubMed ID: 8334128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation.
    Yu G; Smithgall TE; Glazer RI
    J Biol Chem; 1989 Jun; 264(17):10276-81. PubMed ID: 2656706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased DNA binding and transcriptional activity associated with transcription factor Sp1 in K562 cells transfected with the myeloid-specific c-fes tyrosine kinase gene.
    Borellini F; He YF; Aquino A; Yu G; Josephs SF; Glazer RI
    J Biol Chem; 1991 Aug; 266(24):15850-4. PubMed ID: 1874737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
    Lionberger JM; Smithgall TE
    Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minimal c-fes cassette directs myeloid-specific expression in transgenic mice.
    Heydemann A; Warming S; Clendenin C; Sigrist K; Hjorth JP; Simon MC
    Blood; 2000 Nov; 96(9):3040-8. PubMed ID: 11049982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
    Jücker M; Roebroek AJ; Mautner J; Koch K; Eick D; Diehl V; Van de Ven WJ; Tesch H
    Oncogene; 1992 May; 7(5):943-52. PubMed ID: 1373879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transcriptional suppressor located within a downstream intron of the BCR gene.
    Stewart MJ; Cox G; Reifel-Miller A; Kim SY; Westbrook CA; Leibowitz DS
    J Biol Chem; 1994 Apr; 269(14):10820-9. PubMed ID: 8144670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.
    Cheng HY; Schiavone AP; Smithgall TE
    Mol Cell Biol; 2001 Sep; 21(18):6170-80. PubMed ID: 11509660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence.
    Volpi L; Beghini A; Rossi D; Larizza L
    Mamm Genome; 1996 Sep; 7(9):682-5. PubMed ID: 8703122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-Fes protein isoforms correlates with differentiation in myeloid leukemias.
    Carlson A; Berkowitz JM; Browning D; Slamon DJ; Gasson JC; Yates KE
    DNA Cell Biol; 2005 May; 24(5):311-6. PubMed ID: 15869408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a negative regulatory element that inhibits c-mos transcription in somatic cells.
    Zinkel SS; Pal SK; Szeberényi J; Cooper GM
    Mol Cell Biol; 1992 May; 12(5):2029-36. PubMed ID: 1533271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative BCR/ABL transcripts in chronic myeloid leukemia.
    Zaccaria A; Tassinari A; Testoni N; Lauria F; Tura S; Algeri R; Guerrasio A; Rosso C; Saglio G
    Blood; 1990 Oct; 76(8):1663-5. PubMed ID: 2207336
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a transcriptional regulatory region of the rat pancreatitis-associated protein I (PAP I) gene that confers tissue specificity.
    Dusetti NJ; Ortiz EM; Dagorn JC; Iovanna JL
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):643-7. PubMed ID: 7487908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, characterization, and genomic structure of carp JAK1 kinase gene.
    Chang MS; Chang GD; Leu JH; Huang FL; Chou CK; Huang CJ; Lo TB
    DNA Cell Biol; 1996 Oct; 15(10):827-44. PubMed ID: 8892755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of the human myeloperoxidase promoter.
    Austin GE; Zhao WG; Zhang W; Austin ED; Findley HW; Murtagh JJ
    Leukemia; 1995 May; 9(5):848-57. PubMed ID: 7769848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.